申请人:Bristol-Myers Squibb Company
公开号:US06432944B1
公开(公告)日:2002-08-13
There is provided a series of arylacetamidoalanyl derivatives of benzodiazepinones of Formula I
wherein R1 through R7 and n are defined herein, which are inhibitors of &bgr;-amyloid peptide (&bgr;-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions characterized by aberrant extract cellular deposition of amyloid.
提供了一系列苯二氮平酮的芳基乙酰胺基丙氨酸衍生物,其化学式为I,其中R1至R7和n的定义见此处,它们是β-淀粉样肽(β-AP)产生的抑制剂,可用于治疗阿尔茨海默病和其他表现为淀粉样物质异常沉积的疾病。